Education
About Us
Working with TipRanks
Follow Us
NexImmune (NEXI)
OTHER OTC:NEXI
Total Valuation
NexImmune has a market cap or net worth of $139.00. The enterprise value is $1.14M.
Market Cap$139.00
Enterprise Value$1.14M
Share Statistics
NexImmune has 1,394,671 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,394,671
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
NexImmune’s return on equity (ROE) is -9.22 and return on invested capital (ROIC) is -815.77%.
Return on Equity (ROE)-9.22
Return on Assets (ROA)-3.76
Return on Invested Capital (ROIC)-815.77%
Return on Capital Employed (ROCE)-8.32
Revenue Per Employee0.00
Profits Per Employee-5.39M
Employee Count6
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of NexImmune is ―. NexImmune’s PEG ratio is 0.00068.
PE Ratio―
PS Ratio0.00
PB Ratio0.66
Price to Fair Value0.66
Price to FCF-0.07
Price to Operating Cash Flow>-0.01
PEG Ratio0.00068
Income Statement
In the last 12 months, NexImmune had revenue of 0.00 and earned -32.34M in profits. Earnings per share was -30.82.
Revenue0.00
Gross Profit-1.02M
Operating Income-29.19M
Pretax Income-32.34M
Net Income-32.34M
EBITDA-28.17M
Earnings Per Share (EPS)-30.82
Cash Flow
In the last 12 months, operating cash flow was -17.61M and capital expenditures -48.67M, giving a free cash flow of -66.28M billion.
Operating Cash Flow-17.61M
Free Cash Flow-66.28M
Free Cash Flow per Share-47.52
Dividends & Yields
NexImmune pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2696.35
52-Week Price Change-93.75%
50-Day Moving Average0.08
200-Day Moving Average―
Relative Strength Index (RSI)9.86
Average Volume (3m)62.00
Important Dates
NexImmune upcoming earnings date is Aug 7, 2024, After Close (Confirmed).
Last Earnings DateMay 13, 2024
Next Earnings DateAug 7, 2024
Ex-Dividend Date―
Financial Position
NexImmune as a current ratio of 1.06, with Debt / Equity ratio of 1.96%
Current Ratio1.06
Quick Ratio1.06
Debt to Market Cap0.00
Net Debt to EBITDA0.11
Interest Coverage Ratio0.00
Taxes
In the past 12 months, NexImmune has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate<0.01
Enterprise Valuation
NexImmune EV to EBITDA ratio is 0.03, with an EV/FCF ratio of 0.03.
EV to Sales0.00
EV to EBITDA0.03
EV to Free Cash Flow0.03
EV to Operating Cash Flow0.03
Balance Sheet
NexImmune has $2.42M in cash and marketable securities with $0.00 in debt, giving a net cash position of $2.42M billion.
Cash & Marketable Securities$2.42M
Total Debt$0.00
Net Cash$2.42M
Net Cash Per Share$1.74
Tangible Book Value Per Share$3.34
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for NexImmune is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―